ReviewClinical lymphoma, myeloma & leukemia2013

Resistance to tyrosine kinase inhibition therapy for chronic myelogenous leukemia: a clinical perspective and emerging treatment options.

Elias J Jabbour et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.